PDS Planning’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$370K Sell
5,146
-759
-13% -$58.5K 0.02% 340
2025
Q4
$469K Buy
5,905
+911
+18% +$71.8K 0.03% 271
2025
Q3
$376K Buy
4,994
+215
+4% +$14.7K 0.03% 312
2025
Q2
$330K Buy
4,779
+459
+11% +$30.1K 0.02% 331
2025
Q1
$293K Buy
+4,320
New +$259K 0.02% 334
2024
Q4
Sell
-3,864
Closed -$243K 448
2024
Q3
$243K Buy
+3,864
New +$225K 0.02% 360
2024
Q2
Sell
-3,984
Closed -$318K 402
2024
Q1
$318K Buy
3,984
+441
+12% +$33.7K 0.03% 247
2023
Q4
$280K Buy
3,543
+227
+7% +$16.2K 0.03% 252
2023
Q3
$232K Sell
3,316
-248
-7% -$17.6K 0.03% 265
2023
Q2
$246K Buy
3,564
+255
+8% +$18.1K 0.03% 254
2023
Q1
$246K Buy
+3,309
New +$277K 0.03% 230
2022
Q2
Sell
-2,055
Closed -$208K 225
2022
Q1
$208K Sell
2,055
-741
-27% -$77.8K 0.04% 206
2021
Q4
$288K Buy
2,796
+8
+0.3% +$739 0.06% 144
2021
Q3
$237K Buy
2,788
+317
+13% +$26.6K 0.05% 158
2021
Q2
$206K Sell
2,471
-809
-25% -$66.3K 0.05% 172
2021
Q1
$247K Sell
3,280
-152
-4% -$11.1K 0.07% 130
2020
Q4
$234K Buy
+3,432
New +$223K 0.08% 128

Other funds holding CVS

PDS Planning's CVS Position: Q1 2026 in Review

PDS Planning reduced its CVS Health (CVS) stake by 13% in Q1 2026, selling an estimated $58.5K and leaving 5,146 shares worth $370K. The position accounts for 0.02% of the portfolio, ranked #340.

PDS Planning first reported a position in CVS in Q4 2020 and has held it in 17 quarters since. The position peaked at $469K in Q4 2025. 1,866 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • PDS Planning held 5,146 shares of CVS Health worth $370K as of Q1 2026.
  • PDS Planning sold 759 CVS Health shares in Q1 2026, an estimated $58.5K.
  • CVS Health made up 0.02% of PDS Planning's portfolio in Q1 2026, its #340 holding.
  • PDS Planning first reported a position in CVS Health in Q4 2020 and has held it in 17 quarters since.
  • PDS Planning's CVS Health position peaked at $469K in Q4 2025.
  • 1,866 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on PDS Planning's 13F filing for Q1 2026, filed 22 Apr 2026.